Clinical trial
Randomized Controlled Trial Comparing Dimethyl Sulfoxide Cryopreserved Platelets to Liquid Stored Platelets in Patients Undergoing Cardiopulmonary Bypass Surgery (CRYPTICS)
NCT04709705 is registered in ClinicalTrials.gov with Cellphire Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Trial Comparing Dimethyl Sulfoxide Cryopreserved Platelets to Liquid Stored Platelets in Patients Undergoing Cardiopulmonary Bypass Surgery (CRYPTICS)
- Lead sponsor
- Cellphire Therapeutics, Inc.
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- October 27, 2021
- Completion date
- May 8, 2025
- Enrollment
- 161 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac surgery